https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2823%2901384-3/fulltext
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial - The Lancet